Clinical DiabetesPub Date : 2024-01-01Epub Date: 2024-01-15DOI: 10.2337/cd24-pe01
{"title":"Good to Know: Health Equity Bill of Rights.","authors":"","doi":"10.2337/cd24-pe01","DOIUrl":"https://doi.org/10.2337/cd24-pe01","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"42 1","pages":"175-176"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139479498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Nsiah, Patrick J. Campbell, Megha A. Parikh, Lisa E. Hines, Matthew Pickering, David P. Nau
{"title":"Persistence to Basal Insulin: Association With Health Outcomes in a Population With Type 2 Diabetes","authors":"I. Nsiah, Patrick J. Campbell, Megha A. Parikh, Lisa E. Hines, Matthew Pickering, David P. Nau","doi":"10.2337/cd23-0016","DOIUrl":"https://doi.org/10.2337/cd23-0016","url":null,"abstract":"This study examined the association between persistence to basal insulin and clinical and economic health outcomes. The question of whether a persistence measure for basal insulin could be leveraged in quality measurement was also explored. Using the IBM-Truven MarketScan Commercial and Medicare Supplemental Databases from 1 January 2011 to 31 December 2015, a total of 14,126 subjects were included in the analyses wherein 9,898 (70.1%) were categorized as persistent with basal insulin therapy. Basal insulin persistence was associated with lower A1C, fewer hospitalizations and emergency department visits, and lower health care expenditures. Quality measures based on prescription drug claims for basal insulin are feasible and should be considered for guiding quality improvement efforts.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":" 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138962408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Teplizumab: Is It a Milestone for Type 1 Diabetes or a Risk Factor for Other Autoimmune Diseases in the Long-Term?","authors":"Gulsum Ozen, Dario Iafusco","doi":"10.2337/cd23-0073","DOIUrl":"https://doi.org/10.2337/cd23-0073","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"70 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138997534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sensor-Derived A1C: A New and Better Term","authors":"Ian R. Blumer","doi":"10.2337/cd23-0083","DOIUrl":"https://doi.org/10.2337/cd23-0083","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"406 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138974123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-Term Mortality After Charcot Reconstruction","authors":"Cameron Meyer, Amanda Marshall, Patrick Burns","doi":"10.2337/cd23-0030","DOIUrl":"https://doi.org/10.2337/cd23-0030","url":null,"abstract":"Charcot neuroarthropathy is a complicated phenomenon with the potential to cause significant deformity, morbidity, and mortality. Costs associated with Charcot-related complications are substantial, with thousands of amputations occurring annually. The purpose of this study was to retrospectively review a single surgeon's experience and record the 10-year mortality rate among patients after Charcot reconstruction at a single institution between 2007 and 2013. Lower-extremity limb salvage is crucial to reduce the burden of Charcot neuroarthropathy. This article provides an example of the potential long-term success of reconstruction surgery for this condition.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"26 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139008526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nuha A. ElSayed, R. Bannuru, G. Bakris, Joan Bardsley, Ian H. de Boer, Robert A. Gabbay, Janet Gockerman, Rozalina G. McCoy, Elaine McCracken, Joshua J. Neumiller, Scott J. Pilla, Connie M. Rhee
{"title":"Diabetic Kidney Disease Prevention Care Model Development","authors":"Nuha A. ElSayed, R. Bannuru, G. Bakris, Joan Bardsley, Ian H. de Boer, Robert A. Gabbay, Janet Gockerman, Rozalina G. McCoy, Elaine McCracken, Joshua J. Neumiller, Scott J. Pilla, Connie M. Rhee","doi":"10.2337/cd23-0063","DOIUrl":"https://doi.org/10.2337/cd23-0063","url":null,"abstract":"More than one-third of people with diabetes develop diabetic kidney disease (DKD), which substantially increases risks of kidney failure, cardiovascular disease (CVD), hypoglycemia, death, and other adverse health outcomes. A multifaceted approach incorporating self-management education, lifestyle optimization, pharmacological intervention, CVD prevention, and psychosocial support is crucial to mitigate the onset and progression of DKD. The American Diabetes Association convened an expert panel to develop the DKD Prevention Model presented herein. This model addresses prevention and treatment, including screening guidelines, diagnostic tools, and management approaches; comprehensive, holistic interventions; well-defined roles for interdisciplinary health care professionals; community engagement; and future directions for research and policy.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"65 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138594889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole M. Ehrhardt, V. Aroda, Rodolfo J. Galindo, Anne L. Peters, Jay H. Shubrook
{"title":"Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion","authors":"Nicole M. Ehrhardt, V. Aroda, Rodolfo J. Galindo, Anne L. Peters, Jay H. Shubrook","doi":"10.2337/cd23-0047","DOIUrl":"https://doi.org/10.2337/cd23-0047","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"12 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138601457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Donislecel: First Cellular Therapy to Treat Patients With Brittle Type 1 Diabetes","authors":"Ojashwi Giri, J. Goldman","doi":"10.2337/cd23-0091","DOIUrl":"https://doi.org/10.2337/cd23-0091","url":null,"abstract":"","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"35 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139215951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. E. Caballero, Nuha A. ElSayed, S. Golden, R. Bannuru, Brigid Gregg
{"title":"Implicit or Unconscious Bias in Diabetes Care","authors":"A. E. Caballero, Nuha A. ElSayed, S. Golden, R. Bannuru, Brigid Gregg","doi":"10.2337/cd23-0048","DOIUrl":"https://doi.org/10.2337/cd23-0048","url":null,"abstract":"“Implicit bias,” also called “unconscious bias,” refers to associations outside of conscious awareness that adversely affect one’s perception of a person or group. Awareness of implicit bias has been increasing in the realm of diabetes care. Here, the authors highlight several types of unconscious bias on the part of clinicians and patients, including biases based on race, ethnicity, and obesity. They discuss how these biases can negatively affect patient-centered clinical interactions and diabetes care delivery, and they recommend implementation of evidence-based interventions and other health system policy approaches to reduce the potential impact of such biases in health care settings.","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"38 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139266648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}